Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis

Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis

Yosuke Kameoka,1 Fukuko Kishi,1 Minako Koura,2 Yoshio Yamakawa,1 Rora Nagasawa,1 Fuyu Ito,3 Junichiro Matsuda,2 Osamu Suzuki,2 Toshinori Nakayama,4 Kazuo Suzuki1,3–5 1Department of Research and Development, A-CLIP Institute, Ltd., Chiba, Japan; 2Laboratory of Animal Models for Human Disea...

Full description

Bibliographic Details
Main Authors: Kameoka Y, Kishi F, Koura M, Yamakawa Y, Nagasawa R, Ito F, Matsuda J, Suzuki O, Nakayama T, Suzuki K
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:Drug Design, Development and Therapy
Subjects:
ANCA antibody drug
apolipoprotein
HDL
myeloperoxidase (MPO)
SCG/Kj
vasculitis
Online Access:https://www.dovepress.com/efficacy-of-a-recombinant-single-chain-fragment-variable-region-vassf--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/efficacy-of-a-recombinant-single-chain-fragment-variable-region-vassf--peer-reviewed-article-DDDT

Similar Items